The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells
Por um escritor misterioso
Descrição
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
AAV–Cpf1-mediated efficient multiplexed genome editing in human primary
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. - Abstract - Europe PMC
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
Pharmaceuticals, Free Full-Text
IJMS, Free Full-Text
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Molecular Cancer
Applications of CRISPR–Cas in agriculture and plant biotechnology
Development of CRISPR-Cas systems for genome editing and beyond, Quarterly Reviews of Biophysics
Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
Strategies for precise gene edits in mammalian cells: Molecular Therapy - Nucleic Acids
Full article: Putting CRISPR-Cas system in action: a golden window for efficient and precise genome editing for crop improvement
